Cardiac amyloidosis: new insights into diagnosis and management

Area of Science:

• Cardiology
• Pathophysiology
• Medical Diagnostics

Background:

• Amyloidosis impacting the heart leads to severe conditions like congestive heart failure, arrhythmias, and potentially death.
• Cardiac amyloidosis typically manifests as diastolic heart failure, stemming from restrictive cardiomyopathy.
• Amyloid infiltration results in a thickened, stiff heart wall, impairing cardiac relaxation and diastolic compliance.

Purpose of the Study:

• To summarize the clinical presentation and diagnostic findings of cardiac amyloidosis.
• To highlight the progression of cardiac dysfunction caused by amyloid infiltration.
• To underscore the importance of understanding amyloid pathophysiology for targeted therapeutic strategies.

Main Methods:

• Review of clinical signs and symptoms associated with cardiac amyloidosis.
• Analysis of characteristic echocardiographic findings in affected patients.
• Discussion of recent advancements in differentiating amyloid types based on pathophysiology.

Main Results:

• Common symptoms include progressive dyspnea, chest discomfort, and weight loss (cardiac cachexia).
• Echocardiography reveals nondilated ventricles, concentric left ventricular thickening, right ventricular thickening, prominent valves, dilated atria, and thickened interatrial septum.
• Pathophysiological understanding allows for differentiation of amyloid types.

Conclusions:

• Cardiac amyloidosis is a progressive disease with significant impact on heart function.
• Distinct echocardiographic features aid in diagnosis.
• Advances in understanding amyloid pathophysiology are crucial for developing targeted treatments.